5-HT2A receptor antagonist properties of cyamemazine in rat and guinea pig smooth muscle

European Journal of Pharmacology

Volumn 454, Issue 2-3, 2002, Pages 235-239

  Alvarez Guerra, Miriam ^a   Hameg, Ahcène ^b   Bayle, Franck ^c   Dib, Michel ^b   Garay, Ricardo P ^a  

^a FACULTÉ DE MÉDECINE   (France)

^b SANOFI   (France)

^c INSERM   (France)

Author keywords

5 HT2A receptor; Atypical neuroleptic; Cyamemazine; Neuroleptic; Serotonin

Indexed keywords

CYAMEMAZINE; KETANSERIN; SEROTONIN; SEROTONIN 2A RECEPTOR; PHENOTHIAZINE DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BINDING; DRUG EFFECT; DRUG POTENCY; GUINEA PIG; IC 50; ISOLATED ARTERY; MALE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE; TRACHEA; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; IN VITRO STUDY; MUSCLE CONTRACTION; PHYSIOLOGY; WISTAR RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHENOTHIAZINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0037111177     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02489-5     Document Type: Article

References (17)

1. Alcantara A.G., Barcia D. Risperidone and concept of bipolar neuroleptic. Encephale. 25:1999;146-150.
2. 2C-receptor antagonist properties of cyamemazine: significance for its clinical anxiolytic activity. Psychopharmacology. 147:2000;412-417.
3. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 120(4 Suppl.):1997;151-161. (discussion 148-50).
4. Baez M., Mercurio L., Schenck K., Cohen M.L. Relationship between 5-HT2A receptor mRNA density and contractility in trachea and aorta from guinea pig and rat. Life Sci. 55:1994;105-114.
5. Bhana N., Foster R.H., Olney R., Plosker G.L. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs. 61:2001;111-161.
6. Bourin M., Dhonnchadha B.A.N., Colombel M.C., Dib M., Hascoët M. Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice. Behav. Brain Res. 124:2001;87-95.
7. Bymaster F., Perry K.W., Nelson D.L., Wong D.T., Rasmussen K., Moore N.A., Calligaro D.O. Olanzapine: a basic science update. Br. J. Psychiatry. 37:1999;36-40. (Supplement).
8. Deakin J.F. The role of serotonin in panic, anxiety and depression. Int. Clin. Psychopharmacol. 13(Suppl. 4):1998;S1-S5.
9. Dubroca J.M. L'anxiolyse: intérêt de la cyamémazine. Neuro-psy. 1989;4-7.
10. R): profil neuroleptique ou anxiolytique? Inf. Psychiatr. 10:1995;969-970.
11. Leonard B.E. Serotonin receptors and their function in sleep, anxiety disorders and depression. Psychoter. Psychosom. 65:1996;66-75.
12. 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol. Pharmacol. 21:1982;301-314.
13. Meltzer H.Y. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology. 21(Suppl. 2):1999;106S-115S.
14. Paleologue A., Varouchakis H. Etude de l'activité d'un nouveau neuroleptique. Inf. Psychiatr. 52:1976;249-256.
15. Radat F. Cyamémazine: traitement symptomatique des dimensions anxieuses, impulsives et agressives. Inf. Psychiatr. 10:1995;967-968.
16. Watts S.W., Cohen M.L., Mooney P.Q., Johnson B.G., Schoepp D.D., Baez M. Disruption of potential alpha-helix in the G loop of the guinea pig 5-hydroxytryptamine2 receptor does not prevent receptor coupling to phosphoinositide hydrolysis. J. Neurochem. 62:1994;934-943.
17. Watts S.W., Cox D.A., Johnson B.G., Schoepp D.D., Cohen M.L. Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysis. J. Pharmacol. Exp. Ther. 271:1994;832-844.